Yiping Su
Nanjing, 210004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Current mechanisms of primordial follicle activation and new strategies for fertility preservation.
Journal: Molecular human reproduction
Published: October 12, 2020
A fully chimeric IgG antibody for ROR1 suppresses ovarian cancer growth in vitro and in vivo.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 14, 2019
A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo.
Journal: Biochemical and biophysical research communications
Published: March 02, 2019
Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.
Journal: Oncotarget
Published: July 12, 2017
Restricting the induction of NGF in ovarian stroma engenders selective follicular activation through the mTOR signaling pathway.
Journal: Cell death & disease
Published: February 01, 2017
Inhibition of mTOR Signaling Pathway Delays Follicle Formation in Mice.
Journal: Journal of cellular physiology
Published: January 25, 2016
New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 16, 2015
ROR1 expression correlated with poor clinical outcome in human ovarian cancer.
Journal: Scientific reports
Published: March 21, 2014
The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.
Journal: Molecular and cellular biochemistry
Published: October 24, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026